Report Library
View More
Datamonitor Healthcare Oncology Dis...
May 18, 2022
Datamonitor Healthcare Infectious D...
May 17, 2022
Datamonitor Healthcare CV&Met Disea...
May 13, 2022
Datamonitor Healthcare CNS Disease ...
May 6, 2022
Datamonitor Healthcare Infectious D...
May 5, 2022
Datamonitor Healthcare CV&Met: Chem...
May 5, 2022
Datamonitor Healthcare Infectious D...
April 29, 2022
Datamonitor Healthcare I&I Disease ...
April 22, 2022
Datamonitor Healthcare Infectious D...
April 22, 2022
Diffuse Large B-Cell Lymphoma (DLBC...
April 21, 2022
Impact Events
More| Date | Lead Company | Event | Type | Approval Change | Approval Likelihood |
|---|---|---|---|---|---|
| 5/16/22 | Bristol Myers Squibb (BMY) | Opdivo for Bladder Cancer | Subscribers Only | Subscribers Only | Subscribers Only |
| 5/13/22 | UCB (UCB) | Bimzelx for Psoriasis | Subscribers Only | Subscribers Only | Subscribers Only |
| 5/12/22 | Bristol Myers Squibb (BMY) | Deucravacitinib for Psoriasis | Subscribers Only | Subscribers Only | Subscribers Only |
| 5/12/22 | Otsuka (4578) | Inqovi for Acute Myelogenous Leukemia (AML) | Subscribers Only | Subscribers Only | Subscribers Only |
| 5/12/22 | Formosa Pharmaceuticals | APP13007 for Ocular Pain and/or Inflammation (Ophthalmology) | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range | Lead Company | Drug | Expected Catalyst |
|---|---|---|---|
| 03/31/22 | Subscribers Only | Subscribers Only | Trial Data - Top-Line Results |
| 05/12/22 | Subscribers Only | Subscribers Only | Trial Data - Other |
| 05/12/22 | Subscribers Only | Subscribers Only | Trial Data - Other |
| 05/12/22 | Subscribers Only | Subscribers Only | Trial Data - Top-Line Results |
| 05/12/22 | Subscribers Only | Subscribers Only | Trial Data - Other |
